FindTrial
Sign In

Accuracy evaluation of non-invasive hemodynamic monitor HemoVistaTM (BiLab Co. Ltd. Korea) in the critically ill patients

Accuracy evaluation of non-invasive hemodynamic monitor HemoVistaTM (BiLab Co. Ltd. Korea) in the critically ill patients: A prospective observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0008487
Enrollment
20
Registered
2023-06-01
Start date
2023-05-23
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult patients aged 20 or older admitted to the surgical intensive care unit of Asan Medical Center in Seoul, who using arterial catheter cardiac output monitoring device at the time of participation.

Exclusion criteria

Exclusion criteria: Clinically significant arrhythmia (e.g., atrial fibrillation) that may affect the calculation of stroke volume Patients with cardiac pacemakers or defibrillators Patients with mechanical circulation aids, such as an extracorporeal oxygen supply (VA-ECMO) or an aortic balloon pump (IABP) Patients with trauma or skin lesions in the HemoVistaTM sensor attachment (anterior chest) Any other person deemed inappropriate by researchers

Design outcomes

Primary

MeasureTime frame
cardiac output—

Secondary

MeasureTime frame
stroke volume variation—

Countries

Korea, Republic of

Contacts

Public ContactByungmoon choi

Asan Medical Center

rios76@hanmail.net+82-2-3010-1704

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026